Pharma marketing moved beyond the “4 P’s” decades ago (well…some did). Isn’t it time to move beyond the good old “Situation Analysis” too?
In most strategic and business plans, today the best performing companies start with a high level “environmental scan.” Why aren’t we doing the same for Brand Plans? Read More→
Innovara prides itself on continually updating our sales, marketing and other training curricula to prepare our clients for not only today, but for tomorrow. We don’t sell “off the shelf” packages, but each program is customized and specific to the learning need. Why?
Quite simple. Read More→
We are world leaders in medical presentation skills training, working with world leaders in a wide range of medical and scientific fields of expertise. So please trust me when I say that from our experience, a medical professional audience is a most critical one, literally and figuratively. Read More→
Do you know your customer well enough?
If not, then what are you doing and why are you doing it?
I am reminded of the Lean Six Sigma principal: If what you are doing is not driving customer value, then by definition it is waste. Read More→
Barri Blauvelt Innovara CEO and adjunct faculty at U. of Massachusetts co-authors: Identifying Important Breast Cancer Control Strategies in Asia, Latin America and the Middle East/North Africa has just been published on BMC Health Services Research.
There is a lot of emphasis now in the healthcare industry on the word “access”, e.g. creating access, maintain access and crafting access strategies. It slowly crept into our language starting with the new millennium. This decade, “access” is THE buzzword.
“Access” is NOT something that you will not find in text books because it has really been the domain of commercialization strategy in the industry for the last three years. Read More→
The package is one of the most underappreciated marketing tools that companies can use to directly communicate with the patient. With the exception of pills going into a pill bottle, which is unique to the USA, this is your moment to touch and talk to the patient. Read More→
The term marketing in the pharmaceutical industry is being challenged; it is morphing into commercialization strategies, not just marketing. More and more people are feeling that it is no longer about marketing a brand, it is about marketing a disease.
A client recently said to me, Read More→